Search results
Results From The WOW.Com Content Network
The Framingham/ATP III criteria were used to estimate CHD risk in the USA. Data from 11,611 patients from a very large study, the NHANES III, were used. The patients were 20 to 79 years of age and had no self-reported CHD, stroke, peripheral arterial disease, or diabetes. [citation needed]
The Nottingham prognostic index (NPI) is used to determine prognosis following surgery for breast cancer. [1] [2] Its value is calculated using three pathological criteria: the size of the tumour; the number of involved lymph nodes; and the grade of the tumour. [1]
It is a modified ATP derivative stable to enzymatic degradation. [12] It does not require metabolic conversion to an active metabolite. This allows cangrelor's immediate effect after infusion, [ 12 ] and the therapeutic effects can be maintained with continuous infusion. [ 13 ]
The Common Terminology Criteria for Adverse Events (CTCAE), [1] formerly called the Common Toxicity Criteria (CTC or NCI-CTC), are a set of criteria for the standardized classification of adverse events of drugs and treatment used in cancer therapy. The CTCAE system is a product of the US National Cancer Institute (NCI).
The following criteria also exist: [4] White in 1999 proposed "fast-track criteria" to determine if patients can be transferred straight from theatre to Phase II recovery. He proposes a minimum overall score of 12 with no score <1 in any category. He includes consciousness, activity, circulation, respiration, oxygen saturations, pain and emesis.
What is the schedule for the ATP Finals? Sunday, November 12: Singles and doubles group matches (Sessions start at 11am and 5.30pm GMT) Monday, November 13: Singles and doubles group matches ...
The modified Rankin Scale (mRS) is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability. It has become the most widely used clinical outcome measure for stroke clinical trials. [1] [2]
From January 2008 to December 2012, if you bought shares in companies when Charles H. Noski joined the board, and sold them when he left, you would have a -33.6 percent return on your investment, compared to a -2.8 percent return from the S&P 500.